TVTX SG&A Expense Growth
Travere Therapeutics Inc · SG&A Expense Growth
TVTX SG&A Expense Growth
Latest reported27.67%period ending
TVTX FY SG&A Growth (YoY) (0.00% → 27.67%)
Latest values, visible window
High-resolution chart · PNG
TVTX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 27.6705% | |
| -0.5359% | |
| 34.438% | |
| 56.4094% | |
| -7.0067% | |
| 5.3105% | |
| 24.4052% | |
| -0.2924% | |
| 6.0634% | |
| 23.2258% | |
| 33.358% | |
| 253.1766% | |
| -44.1846% | |
| 235,822.1598% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |